title: Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
authors.affiliation: Institute of Nuclear Medicine, University College of London, Middlesex Hospital, Mortimer Street, London, UK. daren.francis@ucl.ac.uk
authors.forename: D L
authors.initials: DL
authors.lastname: Francis
authors.forename: D
authors.initials: D
authors.lastname: Visvikis
authors.forename: D C
authors.initials: DC
authors.lastname: Costa
authors.forename: I
authors.initials: I
authors.lastname: Croasdale
authors.forename: T H
authors.initials: TH
authors.lastname: Arulampalam
authors.forename: S K
authors.initials: SK
authors.lastname: Luthra
authors.forename: I
authors.initials: I
authors.lastname: Taylor
authors.forename: P J
authors.initials: PJ
authors.lastname: Ell
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D015224:Dideoxynucleosides; D019788:Fluorodeoxyglucose F18; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D015224:Dideoxynucleosides; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C002854:alovudine; D005472:Fluorouracil